Just released are the final regulations of The Protecting Access to Medicare Act (PAMA) Section 216. PAMA significantly revises the Medicare payment system for clinical diagnostic laboratory tests by requiring that Medicare payment for clinical laboratories be based on the weighted median of private payer rates along with a number of other provisions.

 

Please note that details on this final rule are still being elucidated and additional specifics are expected to be introduced by CMS in the coming months. Therefore, this webcast is just the first AMP educational event on PAMA implementation. The AMP Economic Affairs Committee will continue to update membership as details emerge and the committee is organizing a session on PAMA at this year's annual meeting.

 

Speaker: Erika Miller, JD

Host: Tara Burke, PhD

 

Duration: 1 hr

Level of Instruction: Basic

 

 

Note: Members of AMP can access this webinar at no cost. Join the AMP Family!

Course Information
Course Date:
June 30, 2016
Course Objectives
  • Provide a brief background on PAMA and present details on the implementation timeline
  • Review the contents of the final rule including: (1) Definition of "Applicable Laboratory", (2) Ratesetting Process and Penalties, (3) Advanced Laboratory Diagnostic Tests (ADLTs), and (4) Coding and other provisions
  • Explain how and to what extent molecular pathology professionals and their laboratories will be affected.
The Who, What, and When of the PAMA Final Rule
Individual topic purchase: Selected
Products
Streaming
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $195.00